Vor Biopharma Inc.
VOR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $3,492 | $8,960 | $0 |
| Gross Profit | $0 | -$3,492 | -$8,960 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $93,310 | $94,315 | $64,550 | $47,529 |
| G&A Expenses | $27,875 | $31,721 | $0 | $21,489 |
| SG&A Expenses | $27,875 | $31,721 | $19,908 | $21,489 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$3,492 | $0 | $0 |
| Operating Expenses | $121,185 | $122,544 | $84,458 | $69,018 |
| Operating Income | -$121,185 | -$126,036 | -$93,418 | -$69,018 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $4,271 | $8,173 | $1,324 | $119 |
| Pre-Tax Income | -$116,914 | -$117,863 | -$92,094 | -$68,899 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$116,914 | -$117,863 | -$92,094 | -$68,899 |
| % Margin | – | – | – | – |
| EPS | -34 | -35 | -46.6 | -37.8 |
| % Growth | 2.9% | 24.9% | -23.3% | – |
| EPS Diluted | -34 | -35 | -46.6 | -37.8 |
| Weighted Avg Shares Out | 3,435 | 3,360 | 1,978 | 1,859 |
| Weighted Avg Shares Out Dil | 3,435 | 3,360 | 1,978 | 1,859 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4,271 | $8,173 | $1,324 | $119 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $3,528 | $3,492 | $8,960 | $1,434 |
| EBITDA | -$117,657 | -$114,371 | -$83,134 | -$67,584 |
| % Margin | – | – | – | – |